Serum human epidermal growth factor 2 extracellular domain as a predictive biomarker for lapatinib treatment efficacy in patients with advanced breast cancer

Chee Khoon Lee, Lucy Davies, Val J. Gebski, Sarah J. Lord, Angelo Di Leo, Stephen Johnston, Charles Geyer, David Cameron, Michael F. Press, Catherine Ellis, Sherene Loi, Ian Marschner, John Simes, Paul De Souza*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    23 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Serum human epidermal growth factor 2 extracellular domain as a predictive biomarker for lapatinib treatment efficacy in patients with advanced breast cancer'. Together they form a unique fingerprint.

    Medicine & Life Sciences